Logo for Plus Therapeutics Inc

Plus Therapeutics Investor Relations Material

Latest events

Logo for Plus Therapeutics Inc

Q3 2024

Plus Therapeutics
Logo for Plus Therapeutics

Q3 2024

14 Nov, 2024
Logo for Plus Therapeutics

Q2 2024

14 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Plus Therapeutics Inc

Access all reports
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the development of innovative therapies for rare cancers. The company leverages nanotechnology and targeted drug delivery platforms to design precision treatments, including radiotherapeutics for central nervous system cancers and other challenging oncological conditions. The company is headquartered in Austin, Texas, and its shares are listed on the NASDAQ.